Filtered By:
Condition: Disability
Management: Food and Drug Administration (FDA)
This page shows you your search results in order of date.
Order by Relevance | Date
Total 129 results found since Jan 2013.
Tobacco Product Use Among Adults - United States, 2021
MMWR Morb Mortal Wkly Rep. 2023 May 5;72(18):475-483. doi: 10.15585/mmwr.mm7218a1.ABSTRACTCommercial cigarette smoking among U.S. adults has declined during the preceding 5 decades (1,2); however, tobacco product use remains the leading cause of preventable disease and death in the United States, and some populations continue to be disproportionately affected by tobacco use (1,2). To assess recent national estimates of commercial tobacco use among U.S. persons aged ≥18 years, CDC, the Food and Drug Administration (FDA), and the National Cancer Institute analyzed 2021 National Health Interview Survey (NHIS) data. In 2021,...
Source: Cancer Control - May 4, 2023 Category: Cancer & Oncology Authors: Monica E Cornelius Caitlin G Loretan Ahmed Jamal Brittny C Davis Lynn Margaret Mayer Iris C Alcantara Linda Neff Source Type: research
Prussian blue nanozymes coated with Pluronic attenuate inflammatory osteoarthritis by blocking c-Jun N-terminal kinase phosphorylation
Biomaterials. 2023 Apr 22;297:122131. doi: 10.1016/j.biomaterials.2023.122131. Online ahead of print.ABSTRACTOsteoarthritis (OA) is a degenerative joint disorder associated with inflammation, functional disability, and high socioeconomic costs. The development of effective therapies against inflammatory OA has been limited owing to its complex and multifactorial nature. The efficacy of Prussian blue nanozymes coated with Pluronic (PPBzymes), US Food and Drug Administration-approved components, and their mechanisms of action have been described in this study, and PPBzymes have been characterized as a new OA therapeutic. Sph...
Source: Biomaterials - April 29, 2023 Category: Materials Science Authors: Chanmi Cho Hyeryeon Oh Jin Sil Lee Li-Jung Kang Eun-Jeong Oh Yiseul Hwang Seok Jung Kim Yong-Soo Bae Eun-Jeong Kim Ho Chul Kang Won Il Choi Siyoung Yang Source Type: research
Recommendations for inversion table therapy
This article discusses the risks of ITT, the current regulatory process for ITT, and the need for a better understanding of the role of ITT in the treatment of spinal pain while optimizing consumer safety.Implications for rehabilitationInversion table therapy (ITT) is a form of spinal traction which is thought to have a role in relieving low back pain due to the gravity-facilitated traction of the spine which distracts the lumbar vertebrae.According to the Food and Drug Administration (FDA) statistics, injuries due to non-powered traction from various medical devices have been rising since 2011.The FDA has regulated ITT fo...
Source: Disability and Rehabilitation - November 29, 2022 Category: Rehabilitation Authors: Andrea Kassay Mohamed A R Soliman Balraj S Jhawar Source Type: research
Prussian blue nanozymes coated with pluronic attenuate inflammatory osteoarthritis by blocking c-Jun N-terminal kinase phosphorylation
Biomaterials. 2022 Dec;291:121851. doi: 10.1016/j.biomaterials.2022.121851. Epub 2022 Oct 25.ABSTRACTOsteoarthritis (OA) is a degenerative joint disorder associated with inflammation, functional disability, and high socioeconomic costs. The development of effective therapies against inflammatory OA has been limited owing to its complex and multifactorial nature. The efficacy of Prussian blue nanozymes coated with Pluronic (PPBzymes), US Food and Drug Administration-approved components, and their mechanisms of action have been described in this study, and PPBzymes have been characterized as a new OA therapeutic. Spherical P...
Source: Biomaterials - November 26, 2022 Category: Materials Science Authors: Chanmi Cho Hyeryeon Oh Jin Sil Lee Li-Jung Kang Eun-Jeong Oh Yiseul Hwang Seok Jung Kim Yong-Soo Bae Eun-Jeong Kim Ho Chul Kang Won Il Choi Siyoung Yang Source Type: research
Tobacco Product Use Among Middle and High School Students - United States, 2022
MMWR Morb Mortal Wkly Rep. 2022 Nov 11;71(45):1429-1435. doi: 10.15585/mmwr.mm7145a1.ABSTRACTTobacco use* is the leading cause of preventable disease, disability, and death among adults in the United States (1). Youth use of tobacco products in any form is unsafe, and nearly all tobacco use begins during youth and young adulthood (2). The Food and Drug Administration (FDA) and CDC analyzed data from the 2022 National Youth Tobacco Survey (NYTS) to estimate current (past 30-day) use of eight tobacco products among U.S. middle (grades 6-8) and high school (grades 9-12) students. In 2022, approximately 11.3% of all students (...
Source: MMWR Morb Mortal Wkl... - November 10, 2022 Category: Epidemiology Authors: Eunice Park-Lee Chunfeng Ren Maria Cooper Monica Cornelius Ahmed Jamal Karen A Cullen Source Type: research
